StockData
Aardvark Therapeutics, Inc. logo

Aardvark Therapeutics, Inc. (AARD) stock

AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.15−0.11 (-8.73%)

Close on Nov 17, 2026Market cap $25.17MP/E –Yield –

Aardvark Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aardvark Therapeutics's market cap was $34.80M on Nov 11, 2026, against $217.02M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$34.80M-87.8%
2025Dec 31, 2025$285.41M–

More Aardvark Therapeutics figures

See a number that looks wrong?